This study looked at the association of mammographic density and molecular subtypes of breast cancer. Visual BI-RADS density scores and volumetric breast density measurements were obtained for 457 patients included in the study, who had been diagnosed with invasive breast cancer between 2003 and 2013. Molecular subtypes (Luminal A, Luminal B, Her-2-Neu and Triple Negative) were categorized according to hormone receptor status (i.e. estrogen receptor (ER), progesterone receptor PR) and Her-2 receptor), tumour grade, and mitotic score. After adjusting for age, race, BMI, family history of breast cancer and lobular carcinoma in situ (LCIS), volumetric breast density was significantly associated with Her-2-neu positive tumours (p = 0.035). A similar analysis showed that this association was not seen for visual BI-RADS categories (p = 0.671 and p = 0.099 for BI-RADS 3 and 4, respectively). The identification of risk factors that are associated with specific breast cancer subtypes could help to inform personalized risk predictions.
High mammographic density is associated with deposition of organised fibrillar collagen and increased stiffness in periductal breast stroma [University of Manchester] McConnell, J.C., O'Connell, O.V., Brennan, K., Gandhi, A., Kirwan, C.C., Astley, S.M., Sherratt, M.J. and Streuli, C.H. This study looked at the relationship between mammographic density, collagen abundance and organization, and periductal tissue stiffness. Fresh tissue samples were obtained from 22 postmenopausal women aged between 54-66 y, who were undergoing riskreducing surgery or mastectomy. For all patients, there was no correlation between the global abundance of collagen and volumetric breast density (VBD; r2=0.0053, p>0.05). In contrast, a significant association was observed between increased volumetric breast density and a greater degree of organized collagen fibrils (r2=0.8658, p<0.0001). The stiffness of the tissue in the periductal region was further assessed in three patients with high mammographic density (MD; i.e. VBD>15%) and three patients with low MD (i.e. VBD<5%) using atomic force microscopy (AFM) . AFM imaging demonstrated that collagen fibrils were organized into larger bundles in women with high MD. Furthermore, periductal tissue from women with high MD exhibited significantly increased local tissue stiffness. Analysis of protein expression in high and low MD patients found no change in the abundance of fibrillar collagens I and II, and an up-regulation of proteins involved in collagen fibril interactions, diameter and cross-linking. A stiffening of the local microenvironment in high MD women may contribute to cancer development.
_______________________________________________________________________________________________________
Predicting the effect of tamoxifen on the breast: Change in measures of breast density, serum markers and SNPs [University of Manchester] Howell, A., Astley, S., Harkness, E., Wiseman, J., Fox J., Stavrinos, P., Wilson, M., Lim, Y., Reece, V., Beetles U., Jain A., Sergeant J., Cuzick, J., Warren R. and Evans G. Using various methods of assessing mammographic density (MD), this study investigated the effect of tamoxifen on MD and compared the results to those observed in the IBIS-I chemoprevention trial. The study comprised 105 higher-risk, premenopausal women aged 33-46 years, who completed 1 year of tamoxifen treatment. MD was measured at baseline (1 year prior to treatment) and then annually for 3 years. MD change from baseline to 1 year post-treatment was assessed using several methods (Quantitative visual to the nearest 5%, visual analogue scale (VAS), Cumulus, Volpara and Quantra). The results from the original IBIS-I reader using 5% increments were reproducible in this new population of women. However, consultant radiologists and radiographic practitioners (using VAS) detected fewer changes in MD, suggesting a difficulty in detecting MD change in general radiological practice. Both Volpara and Quantra indicated little MD change using volumetric percent density. Change in absolute dense area (Cumulus) and absolute dense volume were more sensitive at detecting changes in MD. The results indicated that 72% and 68% of women experienced greater than 10% change in dense volume using Volpara and Quantra, respectively, after tamoxifen treatment. Women who experienced less than 10% change in MD (IBIS-I reader) were more likely to have increased triglycerides after tamoxifen treatment, suggesting that triglycerides could be used as a surrogate marker for MD change. While Cumulus was able to detect changes in MD, it is difficult to implement clinically, and absolute measures of dense volume are likely to be the most useful.
Volumetric breast density improves breast cancer risk prediction [UVA, University of Toronto] Harvey, J.A., Stukenborg, G., Cohn, W.F., Repich, K., Novicoff, W., Alonzo, O., Yaffe, M.D. and Knaus, W.A. The aim of this study was to look at whether the incorporation of volumetric breast density improved breast cancer risk prediction. 839 cases (diagnosed between 2003-2013 with contralateral digital mammograms) and 2,606 matched controls (screened between 2003-2008 with a digital mammogram) were included in this case-control study. Information on risk factors for each woman were obtained using a self-reported electronic questionnaire. Volumetric breast density was determined for each patient using Volpara. Conditional logistic regression using the partial likelihood function from Cox proportional hazard's regression was used to fit risk prediction equations to the dataset. A full prediction model (97 degrees of freedom) yielded a C index of 0.86 and an R-Square of 0.62. A reduced model (15 degrees of freedom) yielded a C index of 0.85 and an R-Square of 0.59. Variables in the reduced model included volumetric breast density, biopsy showing ADH, ALH/LCIS, BMI, HRT use, contraceptives, NSAIDS, smoking, exercise, parity, diabetes, family history of breast cancer, HBOC, Li-Fraumeni or Cowden Syndromes and/or BRCA mutation. Most current risk prediction models do not include breast density and typically have poor discriminatory ability (C-statistics range typically range from 0.60-0.74). Volumetric breast density was a leading independent predictor of case status in both the full (p<0.0001) and reduced model (p=0.0212). Volumetric breast density improved breast cancer risk discrimination, a key consideration for more individualized breast cancer screening.
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INTRODUCTION
While mammographic density is linked to increased breast cancer risk, limited yet conflicting data exists on an association between density and developing specific molecular subtypes of breast cancer.
METHODS
Eligible patients were enrolled in a larger study on breast density, diagnosed with cancer between 2003-2013, and had pathology and films available for review. Density was classified qualitatively from existing radiology reports according to Breast Imaging Reporting and Data System (BIRADS) classification and quantitatively by volumetric breast density measurements using Volpara Solutions TM software. Subtype was assigned by hormone receptor status, tumor grade and mitotic score ( 
RESULTS
Of 604 patients with invasive cancer, 457 had sufficient information for analysis. Among these, 233 (51%) had Luminal A, 79 (17%) Luminal B, 59 (13%) Her-2 +, and 86 (19%) Triple Negative tumors. Younger women and those with denser breasts based on quantitative measurements were more likely to have Her-2+ tumors ( Table 1) ; this association was not seen using the standard BIRADS classification. Triple Negative tumors were less common in patients with LCIS and more common in African Americans. A multinomial logistic regression model controlling for pre-cancer patient factors demonstrated that while quantitative breast density does not significantly differentiate between all molecular subtypes (p=0.140), the association between Her-2+ tumors and denser breasts using continuous quantitative measurements is significant (p=0.035).
CONCLUSION
Women with denser breasts by continuous-scaled quantitative measurements are at higher risk for Her-2+ tumors; an association not delineated using standard BIRADS density classification. Delineating risk factors specific to molecular breast cancer subtype may promote individualized risk prediction models and prevention strategies. 
Molecular
INTRODUCTION
High mammographic density is an established risk factor for breast cancer, whereas epidemiological data on statins and breast cancer risk have been inconclusive. The aim of this study was to address the role of statins in breast cancer risk by studying their effect on mammographic density in a large screening-based cohort.
METHODS
The KARolinska MAmmography project for the risk prediction of breast cancer (KARMA) study includes 70,876 women who performed either a screening or clinical mammography from January 2011 to December 2013. In all, 41,102 women responded to a web-based questionnaire, and their raw digital mammograms were stored and their volumetric mammographic density was estimated using the Volpara™ system. Information on statin use was obtained through the Swedish National Prescription Register. Analysis of covariance was used to study the effect of current statin use on mammographic density, adjusting for a large set of potential confounders. Analyses were stratified by statin lipophilicity and exposure duration. The potential effect modification by hormone replacement therapy (HRT) was analyzed.
RESULTS
Statin use was recorded in approximately 3,300 women (8.1%) of the study population of 41,102, the majority of which was prescribed a lipophilic statin (93.4% of statin users). After multivariable adjustment, volumetric percent density was lower in statin users than in non-users (P<0.001). Further, statin users had a larger non-dense volume than non-users (P<0.001), but no difference in absolute dense volume was detected. No differential effects were observed according to lipophilicity of the statin or drug duration. Interaction analyses revealed effect modification by HRT (P-interaction=0.03) with statin use being associated with a larger dense volume among ever HRT users. 
CONCLUSION
Statin use was associated with a lower mammographic percent density, although no evidence was found for an effect of statins on absolute dense volume. The observed interaction between statin and HRT use requires further investigation.
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INTRODUCTION
High mammographic density (MD) in women is strongly associated with breast cancer risk. However the structural and compositional differences between dense and non-dense breast tissues are not well defined. We determined the relationship between MD, collagen deposition and fibril alignment, and tissue micro-stiffness, in similarly aged individuals without adjacent cancer.
METHODS
Fresh tissue samples were collected from post-menopausal women undergoing breast screening. Collagen deposition and fibril organisation were analysed using light microscopy of wax-sections stained with H&E, Trichrome or Picrosirius Red (with polarising light), and quantified using ImageJ. Local tissue stiffness was measured using atomic force microscopy (AFM) of hydrated tissue. For AFM, 3 x 25 µm 2 areas of each sample were indented at 400 equally spaced points with a 1 µm diameter spherical probe at a loading rate of 1 Hz (Reduced Modulus; YM).
RESULTS
Volumetric MD (Volpara TM ) was determined in 22 women (54-66y) undergoing risk-reducing surgery or mastectomy. Localised regions of elevated density, determined from digital mammograms, were isolated from patients of low and high overall MD, using a new collaborative workflow linking radiologist, surgeon, pathologist, and tissue biobank.
All elevated-density regions contained considerable amounts of stromal connective tissue. However, there were significant differences in these regions from women with low vs high overall MD. Picrosirius Red staining of the localised areas of density revealed that the percentage organised fibrillar collagen content, particularly in the periductal breast stroma, strongly correlated with overall MD.
AFM showed that the localised micro-stiffness of dense areas increased significantly in the breast stroma of patients with high overall MD (Volpara score > 15) compared with those of low overall MD (Volpara score < 5).
CONCLUSION
High MD is a significant risk factor for breast cancer, yet its molecular determinants in the normal, non-cancerous breast are poorly defined. We have shown that high MD is associated with more organised fibrillar collagen, leading to increased stiffness of the periductal breast stroma. Women with low and high MD all have regions with localised density, which contain both stromal connective tissue and epithelial ducts/lobules. However, our results show that these localised areas have differences in collagen organisation and tissue micro-mechanics. We now hypothesise that in the connective tissue of women with high MD, altered synthesis, deposition and turnover of stromal proteins alters the local biomechanical properties within the breast, providing a stiffer microenvironment, and contributing to cancer onset.
INTRODUCTION
There is increasing interest in implementing personalized breast cancer screening strategies rather than relying on population based guidelines. Most risk models do not include breast density and two models that do rely on subjective BI-RADS categories; all have limited discriminatory ability (C-statistics ranging from 0.60-0.74). Our aim was to develop a model that includes an automated objective and numeric volumetric measurement of breast density with other known risk factors to improve risk prediction.
METHODS
A case-control study design was used to evaluate the association between risk factors and breast cancer diagnosis. All women diagnosed with breast cancer during 2003-13 with a digital contralateral mammogram at the University of Virginia at the time of diagnosis were eligible as cases. All women without a breast cancer diagnosis but with a digital mammogram at UVA during 2003-2008 were eligible as controls. Risk factor information was collected using a selfreported electronic questionnaire. Mean automated volumetric breast density (Volpara, NZ) was calculated for each patient as a percentage. Controls were matched to cases in a 2:1 ratio based on age group, race, and education, using the GREEDY algorithm. Case-control selections were made using the weighted sum of the absolute differences between the case and control matching factors. Conditional logistic regression using the partial likelihood function from Cox proportional hazard's regression was used to fit risk prediction equations to the matched case-control study dataset, with stratification for each case matched set. A full model was estimated including all available covariates for use as a model performance reference standard. A reduced model was then estimated including covariates in the full model that had a Wald Chi-Square/degrees of freedom ratio > 1.0. The performance of the full and reduced models was measured using the C index and the maximum R-Square statistic.
RESULTS
The study enrolled 3,445 women; 839 cases and 2,606 controls. Multivariable analysis was conducted using 825 cases and 1,628 controls with 1 or more breast studies reported for the surveyed population. The matching process yielded balanced matching factor values between cases and controls, with no significant differences in age group (p = 0.95), race (p = 0.13), or education (p = 0.86). The full prediction model (with 97 df) yielded a C index of 0.88, and an R-Square of 0.53. The reduced model (with 15 df) had a C index of 0.83 and an R-Square of 0.54. Variables in the reduced model included: mean breast density; biopsy showing ADH, ALH/LCIS; BMI; use of HRT, contraceptives, NSAIDS; smoking; exercise; parity; diabetes; family history of breast cancer, HBOC, Li-Fraumeni, or Cowden Syndromes and/or BRCA mutation. Mean volumetric breast density was a leading independent predictor of case status in both the full (p<0.0001) and reduced models (p=0.0212).
CONCLUSION
Volumetric breast density with other known risk factors may provide more accurate individual risk assessment, enabling clinicians to develop patient centered risk based screening protocols that better inform decision making while including patient preferences. The next steps require independent validation of the risk model in other populations.
